Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael Clay

Concepts (316)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lipoma
4
2022
17
1.750
Why?
Biomarkers, Tumor
10
2024
1339
1.700
Why?
Soft Tissue Neoplasms
5
2024
133
1.170
Why?
Proto-Oncogene Proteins c-mdm2
4
2024
66
1.160
Why?
Liposarcoma
4
2024
31
1.060
Why?
Rhabdomyosarcoma
4
2022
65
0.990
Why?
Adrenal Cortex Neoplasms
3
2023
70
0.960
Why?
In Situ Hybridization, Fluorescence
5
2024
334
0.890
Why?
Adrenocortical Carcinoma
2
2023
72
0.840
Why?
DNA Methylation
5
2024
725
0.810
Why?
Carcinoma, Intraductal, Noninfiltrating
2
2013
61
0.750
Why?
Carcinoma, Ductal, Breast
2
2013
92
0.730
Why?
Tissue Scaffolds
1
2024
223
0.710
Why?
Surgical Wound Infection
1
2024
349
0.660
Why?
Immunohistochemistry
7
2024
1712
0.650
Why?
Extracellular Matrix
1
2024
565
0.620
Why?
Fibroma
1
2020
21
0.610
Why?
Gene Expression Regulation, Neoplastic
5
2021
1432
0.580
Why?
Succinate Dehydrogenase
1
2019
65
0.570
Why?
Gastrointestinal Stromal Tumors
1
2019
41
0.560
Why?
Gastrointestinal Neoplasms
1
2019
74
0.550
Why?
Gene Expression Profiling
4
2025
1792
0.500
Why?
Kidney Neoplasms
4
2024
419
0.490
Why?
Breast Neoplasms
3
2014
2418
0.480
Why?
Cyclin-Dependent Kinase 4
1
2016
52
0.480
Why?
Gene Amplification
2
2020
116
0.480
Why?
DNA Mismatch Repair
1
2014
54
0.420
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2014
42
0.410
Why?
Neoplasms, Second Primary
1
2014
103
0.390
Why?
Receptor, Notch1
1
2013
62
0.390
Why?
Tumor Suppressor Protein p53
4
2023
530
0.390
Why?
Diagnosis, Differential
6
2024
1503
0.380
Why?
Translocation, Genetic
1
2013
127
0.380
Why?
Microtubule-Associated Proteins
1
2013
187
0.360
Why?
Wilms Tumor
3
2023
91
0.350
Why?
Sexually Transmitted Diseases, Viral
1
2010
11
0.320
Why?
Lymphangioleiomyomatosis
1
2011
37
0.320
Why?
Myometrium
1
2011
38
0.320
Why?
Li-Fraumeni Syndrome
2
2021
15
0.310
Why?
Anus Neoplasms
1
2010
33
0.310
Why?
Nuclear Proteins
4
2021
740
0.310
Why?
Uterine Neoplasms
1
2011
98
0.300
Why?
Humans
45
2026
146342
0.280
Why?
Germ-Line Mutation
2
2021
180
0.270
Why?
Male
29
2026
73396
0.250
Why?
Genomics
3
2021
853
0.240
Why?
Child, Preschool
11
2026
11913
0.240
Why?
Female
28
2026
79499
0.230
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2020
1998
0.230
Why?
Child, Hospitalized
1
2026
52
0.230
Why?
Oncogene Proteins, Fusion
2
2024
213
0.220
Why?
Myoepithelioma
1
2024
2
0.220
Why?
Arthritis, Juvenile
1
2025
64
0.220
Why?
Hyphae
1
2024
11
0.220
Why?
Synovial Membrane
1
2025
130
0.210
Why?
Epigenesis, Genetic
3
2024
712
0.210
Why?
Neoplasms
4
2021
2954
0.200
Why?
Child
17
2026
22693
0.200
Why?
Adamantinoma
1
2023
4
0.200
Why?
Young Adult
8
2024
14330
0.200
Why?
Fungi
1
2024
120
0.200
Why?
Oncogene Fusion
2
2020
11
0.200
Why?
Adult
16
2026
41087
0.190
Why?
Antineoplastic Agents
3
2023
2219
0.190
Why?
Adolescent
11
2026
22557
0.190
Why?
X-linked Nuclear Protein
2
2020
9
0.190
Why?
Meniscus
1
2023
23
0.190
Why?
Rhabdomyosarcoma, Embryonal
1
2022
16
0.180
Why?
Wound Healing
1
2024
354
0.170
Why?
Liver Neoplasms
2
2019
776
0.170
Why?
Infant
10
2021
10114
0.170
Why?
Immunoglobulin A
1
2022
205
0.170
Why?
Neuroblastoma
2
2020
177
0.170
Why?
In Situ Hybridization
1
2021
317
0.170
Why?
Penetrance
1
2021
30
0.170
Why?
Mutation
4
2021
4093
0.160
Why?
Bone Neoplasms
1
2023
272
0.160
Why?
Myofibroma
1
2020
3
0.160
Why?
Aged, 80 and over
5
2024
8391
0.160
Why?
Germ Cells
1
2021
67
0.160
Why?
Orthopedic Procedures
1
2023
260
0.160
Why?
DNA Copy Number Variations
1
2021
192
0.160
Why?
Xenograft Model Antitumor Assays
3
2019
930
0.160
Why?
Xanthogranuloma, Juvenile
1
2020
6
0.160
Why?
Introns
1
2021
257
0.160
Why?
Whole Genome Sequencing
1
2021
183
0.160
Why?
Middle Aged
11
2024
36619
0.160
Why?
Anterior Cruciate Ligament Injuries
1
2023
218
0.160
Why?
Tandem Repeat Sequences
2
2017
25
0.160
Why?
Exons
1
2021
361
0.160
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2020
32
0.160
Why?
Sarcoma, Ewing
1
2021
103
0.160
Why?
N-Myc Proto-Oncogene Protein
1
2020
11
0.160
Why?
Receptor, trkA
1
2020
17
0.160
Why?
Neoplasm Recurrence, Local
3
2022
1160
0.150
Why?
Ubiquitin Thiolesterase
1
2020
70
0.150
Why?
Lamin Type A
1
2020
49
0.150
Why?
Aged
8
2024
26432
0.150
Why?
Disease Susceptibility
1
2021
339
0.150
Why?
Phthalazines
1
2020
64
0.150
Why?
Computational Biology
2
2021
678
0.150
Why?
Osteoarthritis, Knee
1
2023
291
0.150
Why?
Cell Nucleus
2
2020
584
0.150
Why?
Phenotype
2
2020
3206
0.150
Why?
Clonal Evolution
1
2019
47
0.150
Why?
Cell Dedifferentiation
1
2019
31
0.150
Why?
Narcotics
1
2019
57
0.150
Why?
Mental Health
1
2026
779
0.140
Why?
Office Visits
1
2019
93
0.140
Why?
Mutation, Missense
1
2021
334
0.140
Why?
Transcriptome
1
2025
1068
0.140
Why?
Muscle Neoplasms
1
2018
9
0.140
Why?
Psychomotor Disorders
1
2018
15
0.140
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2020
139
0.140
Why?
Rhabdoid Tumor
1
2019
99
0.140
Why?
DNA Damage
1
2021
439
0.140
Why?
Scrotum
1
2018
25
0.140
Why?
Anxiety
1
2026
1125
0.140
Why?
Patella
1
2018
30
0.140
Why?
Protein-Tyrosine Kinases
2
2018
429
0.140
Why?
Codon, Nonsense
1
2018
46
0.140
Why?
ErbB Receptors
2
2022
636
0.130
Why?
Immunophenotyping
1
2019
324
0.130
Why?
Neuroendocrine Tumors
1
2019
122
0.130
Why?
Arthroplasty, Replacement, Knee
1
2023
385
0.130
Why?
Craniofacial Abnormalities
1
2018
78
0.130
Why?
Histone Acetyltransferases
1
2018
57
0.130
Why?
Tumor Burden
2
2017
326
0.130
Why?
Urogenital Abnormalities
1
2018
71
0.130
Why?
Health Expenditures
1
2019
198
0.130
Why?
Prognosis
3
2022
4351
0.130
Why?
Fused Kidney
1
2017
2
0.130
Why?
Heterozygote
1
2018
311
0.130
Why?
Mice
8
2022
18297
0.130
Why?
Arthritis, Rheumatoid
2
2025
1185
0.130
Why?
Cell Cycle Proteins
2
2018
630
0.130
Why?
Proto-Oncogene Proteins c-bcl-6
1
2017
11
0.130
Why?
Sarcoma, Clear Cell
1
2017
10
0.130
Why?
Fibrosarcoma
1
2017
22
0.130
Why?
Beckwith-Wiedemann Syndrome
1
2016
7
0.130
Why?
Parents
1
2026
1394
0.120
Why?
Drug Prescriptions
1
2019
314
0.120
Why?
Single-Cell Analysis
1
2020
370
0.120
Why?
Opiate Substitution Treatment
1
2019
195
0.120
Why?
Intellectual Disability
1
2018
183
0.120
Why?
Hemangioendothelioma
1
2016
13
0.120
Why?
Insurance, Health
1
2019
318
0.120
Why?
Kasabach-Merritt Syndrome
1
2016
8
0.120
Why?
Ectodermal Dysplasia
1
2016
16
0.120
Why?
Genetic Variation
1
2021
996
0.120
Why?
Scalp
1
2016
38
0.120
Why?
Depression
1
2026
1575
0.120
Why?
Reproducibility of Results
2
2015
3416
0.120
Why?
Retrospective Studies
6
2024
17438
0.110
Why?
Troponin
1
2015
50
0.110
Why?
Buprenorphine
1
2019
197
0.110
Why?
Sarcoma, Kaposi
1
2016
83
0.110
Why?
Hospitalization
1
2026
2475
0.110
Why?
Mismatch Repair Endonuclease PMS2
1
2014
4
0.110
Why?
MutL Protein Homolog 1
1
2014
11
0.110
Why?
MutS Homolog 2 Protein
1
2014
12
0.110
Why?
Clone Cells
2
2017
259
0.110
Why?
DNA Repair Enzymes
1
2014
29
0.110
Why?
Chromosome Aberrations
2
2017
167
0.110
Why?
Genetic Predisposition to Disease
3
2021
2488
0.100
Why?
Drug Resistance, Neoplasm
1
2019
893
0.100
Why?
Adenosine Triphosphatases
1
2014
158
0.100
Why?
Repressor Proteins
1
2017
430
0.100
Why?
Proto-Oncogene Proteins
1
2017
616
0.100
Why?
DNA Mutational Analysis
1
2014
410
0.100
Why?
Predictive Value of Tests
2
2017
2113
0.100
Why?
Breast
1
2013
155
0.090
Why?
Proto-Oncogene Proteins B-raf
1
2014
231
0.090
Why?
Trastuzumab
1
2013
119
0.090
Why?
Algorithms
1
2020
1849
0.090
Why?
Sensitivity and Specificity
1
2016
1998
0.090
Why?
Adaptor Proteins, Signal Transducing
1
2014
429
0.090
Why?
Disease Management
1
2015
651
0.080
Why?
Stromal Cells
2
2025
123
0.080
Why?
Antibodies, Monoclonal, Humanized
2
2019
992
0.080
Why?
Mastectomy
1
2013
189
0.080
Why?
Epithelioid Cells
1
2011
9
0.080
Why?
Genomic Imprinting
2
2023
28
0.080
Why?
Opioid-Related Disorders
1
2019
634
0.080
Why?
Penile Neoplasms
1
2010
7
0.080
Why?
Risk Factors
2
2015
10921
0.080
Why?
Uterine Cervical Dysplasia
1
2010
26
0.080
Why?
Kidney
1
2018
1498
0.080
Why?
Disease Models, Animal
1
2021
4580
0.080
Why?
Animals
10
2023
38107
0.080
Why?
DNA, Neoplasm
1
2010
160
0.080
Why?
Brain Neoplasms
1
2019
1325
0.080
Why?
Papillomaviridae
1
2010
113
0.080
Why?
Combined Modality Therapy
1
2013
1271
0.070
Why?
Mice, Nude
2
2021
668
0.070
Why?
Critical Illness
1
2015
908
0.070
Why?
Neoplasm Staging
1
2013
1488
0.070
Why?
Sequence Analysis, RNA
2
2021
441
0.070
Why?
Prospective Studies
2
2026
8123
0.070
Why?
Liver
1
2016
1864
0.070
Why?
Fibroblasts
2
2025
1034
0.070
Why?
Tomography, X-Ray Computed
1
2018
2786
0.070
Why?
DNA-Binding Proteins
1
2014
1468
0.060
Why?
Uterine Cervical Neoplasms
1
2010
269
0.060
Why?
Databases, Factual
1
2013
1493
0.060
Why?
DNA
2
2023
1421
0.060
Why?
Receptor, Notch3
1
2025
8
0.060
Why?
Chemokine CXCL13
1
2025
15
0.060
Why?
Receptors, CXCR3
1
2025
17
0.060
Why?
Receptors, CXCR5
1
2025
29
0.060
Why?
Rodent Control
1
1985
2
0.060
Why?
Leptospira interrogans
1
1985
4
0.060
Why?
Chemokine CXCL9
1
2025
38
0.060
Why?
Leptospirosis
1
1985
8
0.060
Why?
Chemokine CXCL12
1
2025
85
0.060
Why?
Carcinoma, Squamous Cell
1
2010
628
0.060
Why?
Signal Transduction
3
2025
5246
0.050
Why?
Gene Fusion
1
2024
31
0.050
Why?
Diaphyses
1
2023
10
0.050
Why?
Ulna
1
2023
35
0.050
Why?
Occupational Diseases
1
1985
164
0.050
Why?
Activating Transcription Factor 4
1
2023
23
0.050
Why?
Fibula
1
2023
37
0.050
Why?
Proteasome Inhibitors
1
2023
42
0.050
Why?
Adenocarcinoma
1
2010
927
0.050
Why?
Proteasome Endopeptidase Complex
1
2023
155
0.050
Why?
Imidazoles
1
2023
245
0.040
Why?
Drug Resistance
1
2022
145
0.040
Why?
Carcinoma, Renal Cell
1
2024
231
0.040
Why?
Muscle Development
1
2022
114
0.040
Why?
Gene Knock-In Techniques
1
2021
60
0.040
Why?
Myositis Ossificans
1
2020
4
0.040
Why?
Periosteum
1
2020
14
0.040
Why?
Piperazines
1
2023
368
0.040
Why?
Fasciitis
1
2020
11
0.040
Why?
Cellular Senescence
1
2023
225
0.040
Why?
Brazil
1
2021
179
0.040
Why?
Biopsy
1
2024
1075
0.040
Why?
Dasatinib
1
2020
58
0.040
Why?
Freezing
1
2020
84
0.040
Why?
Complement Activation
1
2023
412
0.040
Why?
Autoantigens
1
2022
426
0.040
Why?
Gene Rearrangement
1
2020
156
0.040
Why?
Etoposide
1
2019
169
0.040
Why?
CD8-Positive T-Lymphocytes
1
2025
931
0.040
Why?
Carboplatin
1
2019
168
0.040
Why?
Receptors, Immunologic
1
2020
210
0.040
Why?
Mice, SCID
1
2019
360
0.040
Why?
Organophosphorus Compounds
1
2019
84
0.040
Why?
Prevalence
1
2026
2861
0.040
Why?
Neoplasm Grading
1
2019
313
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2018
43
0.030
Why?
Genotype
1
2023
1879
0.030
Why?
Tumor Microenvironment
1
2023
747
0.030
Why?
Tumor Cells, Cultured
1
2020
882
0.030
Why?
Unfolded Protein Response
1
2018
58
0.030
Why?
Immunoglobulin G
1
2022
901
0.030
Why?
Longitudinal Studies
1
2026
3017
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p57
1
2017
5
0.030
Why?
Epigenomics
1
2018
124
0.030
Why?
Chromosomes, Human, Pair 11
1
2017
61
0.030
Why?
Genes, p53
1
2017
56
0.030
Why?
Bortezomib
1
2017
54
0.030
Why?
Macrophages
1
2025
1532
0.030
Why?
Membrane Glycoproteins
1
2020
495
0.030
Why?
Infant, Newborn
2
2021
6460
0.030
Why?
Hydroxamic Acids
1
2017
96
0.030
Why?
Cohort Studies
2
2020
6077
0.030
Why?
Heterografts
1
2017
143
0.030
Why?
Reactive Oxygen Species
1
2020
610
0.030
Why?
Vincristine
1
2017
148
0.030
Why?
Camptothecin
1
2017
139
0.030
Why?
Pyrimidinones
1
2017
124
0.030
Why?
Mice, Transgenic
1
2021
2134
0.030
Why?
Family
1
2020
690
0.030
Why?
beta Catenin
1
2017
250
0.030
Why?
High-Throughput Screening Assays
1
2017
179
0.030
Why?
Molecular Targeted Therapy
1
2018
447
0.030
Why?
Antibodies, Monoclonal
1
2022
1512
0.030
Why?
Medicaid
1
2019
477
0.030
Why?
Autoantibodies
1
2022
1500
0.030
Why?
Apoptosis
1
2023
2439
0.030
Why?
Drug Therapy, Combination
1
2017
1036
0.030
Why?
Leukocyte Transfusion
1
1994
5
0.030
Why?
Granulocytes
1
1994
82
0.030
Why?
Precision Medicine
1
2018
462
0.030
Why?
Polymerase Chain Reaction
1
2017
1031
0.030
Why?
Pyrimidines
1
2017
532
0.020
Why?
Indoles
1
2017
511
0.020
Why?
Pyrazoles
1
2017
517
0.020
Why?
Medicare
1
2019
920
0.020
Why?
Cells, Cultured
1
2021
4118
0.020
Why?
Mycoses
1
1994
87
0.020
Why?
Neutropenia
1
1994
153
0.020
Why?
Mitochondria
1
2020
997
0.020
Why?
Mice, Knockout
1
2020
3125
0.020
Why?
Bone Marrow Transplantation
1
1994
301
0.020
Why?
Healthcare Disparities
1
2019
733
0.020
Why?
Aging
1
2023
1996
0.020
Why?
Acute Coronary Syndrome
1
2015
299
0.020
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2015
449
0.020
Why?
Proteomics
1
2018
1203
0.020
Why?
United States Department of Veterans Affairs
1
2015
777
0.020
Why?
Hospital Mortality
1
2015
1051
0.020
Why?
Cell Line, Tumor
1
2018
3545
0.020
Why?
United States
2
2019
16136
0.020
Why?
Mice, Inbred C57BL
1
2021
6034
0.020
Why?
Registries
1
2017
2400
0.020
Why?
Epidemiologic Methods
1
1985
91
0.010
Why?
Michigan
1
1985
203
0.010
Why?
Treatment Outcome
1
2019
11821
0.010
Why?
Biomarkers
1
2015
4340
0.010
Why?
Rats
1
1985
5586
0.010
Why?
Aspergillus
1
1994
18
0.010
Why?
Candidiasis
1
1994
64
0.010
Why?
Candida albicans
1
1994
62
0.010
Why?
Clay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)